JFG
CRBU icon

Jefferies Financial Group’s Caribou Biosciences CRBU Stock Holding History

Jefferies Financial Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,262
Closed -$63.2K – 1723
2026
Q1 		$63.2K Sell
33,262
-11,578
-26% -$19.9K ﹤0.01% 1634
2025
Q4 		$71.3K Sell
44,840
-2,360
-5% -$4.95K ﹤0.01% 1737
2025
Q3 		$110K Buy
+47,200
New +$89.1K ﹤0.01% 1331
2024
Q1 		– Sell
-20,000
Closed -$115K – 1675
2023
Q4 		$115K Sell
20,000
-280,000
-93% -$1.38M ﹤0.01% 1533
2023
Q3 		$1.43M Buy
+300,000
New +$1.86M 0.01% 718

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jefferies Financial Group's CRBU Position: Q2 2026 in Review

Jefferies Financial Group sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 33,262 shares — an estimated $63.2K sold.

Jefferies Financial Group first reported a position in CRBU in Q3 2023 and held it in 5 quarters. The position peaked at $1.43M in Q3 2023. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Jefferies Financial Group reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 33,262 Caribou Biosciences shares in Q2 2026, an estimated $63.2K.
  • Jefferies Financial Group first reported a position in Caribou Biosciences in Q3 2023 and held it in 5 quarters.
  • Jefferies Financial Group's Caribou Biosciences position peaked at $1.43M in Q3 2023.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.